Greetings. And welcome to the Tiptree Second Quarter 2018 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Sandra Bell, Chief Financial Officer. Please go ahead.

Good morning, and welcome to our second quarter 2018 earnings call. We are joined today by our Executive Chairman, Michael Barnes. We have posted the earnings release and presentation on our website at tiptreeinc.com. Our remarks today are qualified in their entirety by the disclaimers on page 1 of the presentation. This presentation supplements our SEC filings and is provided solely for information purposes. Throughout the presentation, we make forward-looking statements. Our businesses are subject to risks and uncertainties which are outlined in our SEC filings and which could impact our expectations of future results. Except as required by securities law, we undertake no obligation to update any forward-looking statement. In addition, we use non-GAAP measures which we believe provide supplemental information about our business and are useful to investors. As these measures are not GAAP, they should not be used as a substitute for GAAP disclosures. The appendix provides a reconciliation of each of these measures to their GAAP equivalent. With that, we will turn the call over to Michael.

Thank you Sandra and good morning to everyone. As we are just over halfway through 2018, we thought it would make sense to assess how we are doing against our objective. We started 2018 with three key objectives. Grow the insurance business while maintaining our focus on strong underwriting performance. Grow and refine the investments within Tiptree Capital and generate enhanced risk adjusted long-term return beginning with growth in our specialty insurance business. Both gross and net written premiums are up 12% driven by organic growth and credit and warranty line. Strong consumer demand in the US economy for credit and products ranging from autos to furniture is contributing to the growth. Our combined ratio remains steady in the low 90s, demonstrating an ability to underwrite profitably as we grow written premium and continue to onboard new distribution partners. We believe our expansion in Europe will support organic growth and complement the US business. We continue to look for attractive acquisition opportunities with a focus on businesses that can build on our current offerings or offer adjacent products and technologies. We remain disciplined with acquisitions aiming to find platforms at the right price where we can continue to underwrite profitably and enhance investment portfolio returns over the long run. Our second objective is to grow and refine the investments within Tiptree Capital. As we mentioned in the first quarter, the sale of Care to invest was completed in February, resulting in a $46.2 million pre-tax gain and $0.91 per share increase to Book value. In May, we refinance the corporate debt facility, adding to available liquidity as we continue to seek attractive, long-term investment in both our insurance portfolio and Tiptree capital. The net result of all these actions from an operating perspective drove growth and revenues of over 5%,…

Thank you, Michael. On page 4, we highlight the company's key metrics for the second quarter and year-to-date 2018. Net income for the second quarter was $0.9million, an increase of $6.2 million from the prior period. The increase was primarily driven by improvement in income at our specialty insurance subsidiary, and lower corporate expenses. Net income for the year-to-date period was $29.9 million, up significantly from 2017 primarily driven by our gain on the sale of Care in addition to the positive factors impacting the quarter. Within the year-to-date financial, we have taken $11.5 million of unrealized losses primarily from mark-to-market on our Invesque share. Operating EBITDA for the quarter was $15.1 million, up modestly while operating EBITDA for the year-to-date period was $24 million, down 10% from the year earlier period. While both periods were positively impacted by growth in our insurance operations, in the year-to-date period positive performance was more than offset by lower distributions from the sale of our credit related investments. On the bottom of the page, we show a walk from operating EBITDA to pre-tax income highlighting the key drivers of the differences between the two metrics. Book value per share increased to $10.74, up $0.87 from the prior year as the gain on sale of Care, improvement in insurance results, and share buyback overcame any negative factors. Turning to page 5, we highlight our capital allocation and respective return to assist investors in valuing Tiptree. We have detailed our capital between specialty insurance and Tiptree Capital. When considering capital allocation decisions, we look at total capital which includes corporate debt. We evaluate our return on capital using trailing 12 months operating EBITDA which for the most recent period was $58.2 million. Our total return of approximately 8.9% down from the prior year was driven…

Thanks Sandra. To provide a quick summary. Throughout the first half, we executed on several strategic objectives to expand our insurance business and simplify our corporate structure. We expect to continue to grow our insurance investment portfolio in line with the business, and to leverage Tiptree's investment expertise to increase the total return of the insurance portfolio over the long term. Within Tiptree Capital, we expect to reinvest capital as opportunities arise. In conclusion, we are pleased with our first-half result and look forward to building on this momentum in the second half of the year. Now we will open up the lines for questions.

[Operator Instructions] Our first question comes from Andrew Cowen of Community Capital. Please proceed with your question.

Hi, guys, young lady, Sandra, sorry. What --it was a nice uptick in profitability at the insurance --Fortegra, what drove that primarily?

Sandra, do you want to that?

Sure. For the most part that's being driven by the organic growth initiatives that we've been undertaking in our insurance business. The primary driver was in credit protection and secondarily within warranty as we add new distribution partners and the economy obviously is supportive of our business model.

So it's just more people taking out those personal loans.

More people buying cars, more people buying furniture, yes.

Got it, okay.

And I'll just add one quick thing there. I mean, Rick Kahlbaugh, is the CEO of Fortegra, he has done I think a fantastic job of continuing momentum and organic growth in his business. And as we've said publicly we are also looking to make acquisitions when the price is right. When we see things that naturally are additive to the overall enterprise values. So but for this last quarter, I'd attributed partly to the overall economic environment which is robust. And I'd say the efforts of Rick and his team at Fortegra; he has done a great job great.

Great. And can you discuss the opportunity set in Europe? Is it something that you think could be as big as the United States or what are your thoughts there?

Sandra, you want to start I'll add.

Sure. On balance it's a less mature market. I think our focus is primarily on expanding into credit protection with less to lesser extent auto warranty. I don't think we think as big as the US just because the markets not as big, and it'll take some time to develop the product there, but we do see it as a strong opportunity to help support the growth we have overall.

Yes and I was just going to say we really have just gotten started. I think we do see it as a way of adding to overall growth of the business. We do want to move slowly. We're not going to be jumping into the space. I think we're going to keep it consistent with the lines of business that we have traditionally operated in the state. So you should expect to see that grow over time, but we're going to move slowly and carefully. And again, we really just have gotten started.

Okay, great. And along the lines of the of the investment portfolio is sort of that $10 million to $15 million a quarter is that sort of the pace that you're looking to add to the float or is there no schedule or budget on that front? It, sort of, what it is?

We're looking to consistently grow. I think that's --that looking at organic growth we should expect to see the portfolio continue to grow in that --at that pace absent making an acquisition. And already I said, we're out there always looking to make out on acquisition in the warranty insurance especially insurance base. So with an acquisition, we'd see that grow more quickly but absent that you should expect it to grow at that pace.

Great. Well, I mean it was a nice uptick and the sort of operating profitability. And do you think that upper-- so it's kind of hard to --I haven't been able to sort breakdown what the operating cash profitability was for the quarter. Do you have a breakdown there anywhere?

Andrew I think the best thing to look at and we added this page; this is a new page in the investor presentation that you can find online. On page 5 we show the entry Tiptree Capital allocation and we show operating EBITDA. In terms of earning capacity of the business, earnings potential of business, we think operating EBITDA is sort of a consistent measured sort of profitably - EBITDA generation of the overall businesses. So I turn your focus to that, absent I'd say the mark-to-market volatilities that will experience on Invesque which is an outsized position having combined our Care business with Invesque and having those shares locked up for some time. We're going to experience natural volatility of the overall equity market and particular to release the healthcare, real estate. But absent of mark -to- market volatility of that particular position, we see our overall earnings as strong.

So that 58 - all right so that's a pretty big uptick then from where you were even at the first quarter.

That's trailing 12 months but yes but --we feel pretty good about where we are.

Great and in regards to the Invesque share lockup, if they do like an organized offering would your shares still be locked at that point or is the transfer just you can't sell in the open market?

In an organized offering, we can't - the answer is we can't sell in the open market. I can't say that we're anticipating that there's going to be anything done in the near term that would allow us to move those shares more quickly. But we certainly in an organized sale, I believe we would have the ability to participate but I would not hold that out as an expectation.

There are no further questions. I'd like to turn the call back to Ms. Sandra Bell for closing comments.

Thank you, Daren. And thanks everyone for joining us today. As always, if you have any questions, please feel free to reach out to me directly. This concludes our second quarter conference call.

This concludes this conference. You may disconnect your lines at this time. Thank you for your participation.